logo
Loading...
Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia
Medicine and HealthClinical and Translational Medicine

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia

X. Zhou, W. Lang, et al.

This groundbreaking study by Xinping Zhou and colleagues reveals that circulating tumor DNA (ctDNA) is a promising minimally invasive biomarker for monitoring treatment outcomes in myelodysplastic syndromes and acute myeloid leukemia. The findings highlight the significant correlation between ctDNA concentrations and tumor burden, underscoring its potential in predicting patient survival and detecting early relapses.... show more
Introduction
Literature Review
Methodology
Key Findings
Discussion
Conclusion
Limitations
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 22+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny